This chapter reviews multiple aspects of hepatic fibrosis, including its pathophysiologic
mechanisms, natural history, clinical features, current and future tools for diagnosing fibrosis …

Hepatitis B virus (HBV) causes a generally non-cytopathic infection in the liver. Even though
HBV is a DNA virus, it replicates via reverse transcription which is coordinated within the …

Abstract Background Hepatitis B virus (HBV) infection is one of the most common risk factors
for intrahepatic cholangiocarcinoma (ICC). However, there is no direct evidence of a causal …

Hepatitis B immunoglobulin is used for prophylaxis against hepatitis B virus (HBV) and is
thought to act by neutralization of virions and hepatitis B virus surface antigen (HBsAg) …

Objectives: The aim of this study was to examine the methylation status of intrahepatic
hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) and to elucidate the …

The objective of this study was to identify the key glutathione S-transferase (GST) isozymes
involved in the detoxification of Aflatoxin B 1 (AFB 1) in ducks' primary hepatocytes. The full …

Aim Hepatitis B virus (HBV) integration is one of the mechanisms contributing to
hepatocellular carcinoma (HCC) development. However, the status of HBV integration in …

This study was designed to test the efficacy of antiviral treatment with entecavir (ETV) in
combination with DNA vaccines expressing duck hepatitis B virus (DHBV) antigens as a …

The clinical management of chronic hepatitis B infection has entered a new era with the
introduction and widespread use of oral nucleoside analogues such as lamivudine and …

Background: Hepatitis B virus (HBV) carriers are at high risk for the development of
hepatocellular carcinoma (HCC), but there are no reliable markers that will identify such …